Research Paper Volume 15, Issue 24 pp 14996—15024
ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network
Figure 2. WGCNA. (A) A Scale-free fit index as a function of soft-thresholding power. (B) The mean connectivity is a function of soft-thresholding powers. (C) Highly interconnected groups of genes were clustered and modules are represented by distinct colours in the horizontal bar. (D) Heatmap showed the correlations of module eigengenes with clinical traits. The numbers in each cell represent the correlation coefficients and P-value between clinical trait and module eigengenes.